FLD Fatty Liver Disease
Fatty Liver, A Big, Fatty Opportunity for Big Pharma
A Big, Fatty Opportunity for Big Pharma The next multibillion-dollar therapeutic area for drug companies may be fatty liver disease, but there are a few practical hurdles to overcome first.  The next big opportunity for pharmaceutical companies is in a disease many people don’t know about. Investors and industry observers should expect to hear…
Read MoreLiver disease could be picked up much sooner by nurse-led tests
PUBLIC RELEASE: 21-DEC-2018 UNIVERSITY OF SOUTHAMPTON Research carried out by scientists at the University of Southampton has shown that simple tests in GP surgeries could potentially double the diagnosis rate of liver disease where patients are not displaying any symptoms. Chronic liver disease is an escalating problem both in the United Kingdom and worldwide. In the…
Read More